Heart failure care is available across all phases of a patient’s care journey through the Heart Failure Center of Excellence's Comprehensive Subspecialty Clinics. Our team of experts provide comprehensive care for patients diagnosed with Amyloidosis, HFpEF, and Hypertrophic Cardiomyopathy, with a focus on improving patient quality of life and outcomes.
Amyloid Program
The first and only of its kind providing comprehensive care for patients with Transthyretin (TTR) amyloidosis and AL amyloidosis. Our multidisciplinary system of care between core faculty of cardiology, neurology, hematology, and gastro-enterology ensures comprehensive patient evaluations and optimal care determinations.
Program Leader
Joel Fernandez, MD
Program Lead,
Cardiac Amyloid Program
Transplant Cardiologist,
TGH Heart & Vascular Institute
HFpEF Program
Our Heart Failure Preserved Ejection Fraction (HFpEF) Program features a team of advanced heart failure physicians who manage the entire spectrum of HFpEF patients, from diagnostic hemodynamic testing for difficult-to-diagnose HFpEF to phenotype-specific medical management.
Program Leaders
Jessica Huang, MD
Co-Program Lead,
HFpEF Program
Advanced Heart Failure Cardiologist,
TGH Heart & Vascular Institute
Jason Feliberti, MD
Co-Program Lead,
HFpEF Program
Advanced Heart Failure Cardiologist,
TGH Heart & Vascular Institute
Hypertrophic Cardiomyopathy (HCM) Program
1st in Tampa to Offer CAMZYOS® (mavacamten) for HCM Treatment
The Hypertrophic Cardiomyopathy (HCM) Program specializes in comprehensive evaluation and treatment of HCM in individuals and genetic testing for family members. We provide the latestin imaging modalities for accurate diagnosis and comprehensive medical management, with experience and protocols for CAMZYOS® (mavacamten), a newly FDA-approved therapy. Through a multidisciplinary collaboration with our partners in the TGH Cardiothoracic Surgery Center, we also offer the most advanced surgical interventions, including myectomies and valve repair/replacement.
Unique Genetic Counseling Program
Our cardiac geneticists determine inherited forms of cardiomyopathy and potential treatments.
Program Leader
Robby Wu, DO
Program Lead
Hypertrophic Cardiomyopathy Program,
TGH Heart & Vascular Institute
Asst. Professor of Medicine
Advanced Heart Failure and Transplant Cardiology,
USF Health Morsani College of Medicine